Ruanne V Barnabas1, Heidi van Rooyen2, Elioda Tumwesigye3, Pamela M Murnane4, Jared M Baeten5, Hilton Humphries2, Bosco Turyamureeba3, Philip Joseph2, Meighan Krows4, James P Hughes6, Connie Celum5. 1. Departments of Global Health and Medicine, University of Washington, Seattle, WA ; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA. 2. Human Sciences Research Council, Sweetwaters, KwaZulu-Natal, South Africa. 3. Integrated Community-Based Initiatives, Kabwohe, Uganda. 4. Departments of Global Health and Medicine, University of Washington, Seattle, WA. 5. Departments of Global Health and Medicine, University of Washington, Seattle, WA ; Department of Epidemiology, University of Washington, Seattle, WA. 6. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA ; Department of Biostatistics, University of Washington, Seattle, WA, USA.
Abstract
OBJECTIVE: Antiretroviral therapy (ART) significantly decreases HIV-associated morbidity, mortality, and HIV transmission through HIV viral load suppression. In high HIV prevalence settings, outreach strategies are needed to find asymptomatic HIV positive persons, link them to HIV care and ART, and achieve viral suppression. METHODS: We conducted a prospective intervention study in two rural communities in KwaZulu-Natal, South Africa, and Mbabara district, Uganda. The intervention included home HIV testing and counseling (HTC), point-of-care CD4 count testing for HIV positive persons, referral to care, and one month then quarterly lay counselor follow-up visits. The outcomes at 12 months were linkage to care, and ART initiation and viral suppression among HIV positive persons eligible for ART (CD4≤350 cells/μL). FINDINGS: 3,393 adults were tested for HIV (96% coverage), of whom 635 (19%) were HIV positive. At baseline, 36% of HIV positive persons were newly identified (64% were previously known to be HIV positive) and 40% were taking ART. By month 12, 619 (97%) of HIV positive persons visited an HIV clinic, and of 123 ART eligible participants, 94 (76%) initiated ART by 12 months. Of the 77 participants on ART by month 9, 59 (77%) achieved viral suppression by month 12. Among all HIV positive persons, the proportion with viral suppression (<1,000 copies/mL) increased from 50% to 65% (p=<0.001) at 12 months. INTERPRETATION: Community-based HTC in rural South Africa and Uganda achieved high testing coverage and linkage to care. Among those eligible for ART, a high proportion initiated ART and achieved viral suppression, indicating high adherence. Implementation of this HTC approach by existing community health workers in Africa should be evaluated to determine effectiveness and costs.
OBJECTIVE: Antiretroviral therapy (ART) significantly decreases HIV-associated morbidity, mortality, and HIV transmission through HIV viral load suppression. In high HIV prevalence settings, outreach strategies are needed to find asymptomatic HIV positive persons, link them to HIV care and ART, and achieve viral suppression. METHODS: We conducted a prospective intervention study in two rural communities in KwaZulu-Natal, South Africa, and Mbabara district, Uganda. The intervention included home HIV testing and counseling (HTC), point-of-care CD4 count testing for HIV positive persons, referral to care, and one month then quarterly lay counselor follow-up visits. The outcomes at 12 months were linkage to care, and ART initiation and viral suppression among HIV positive persons eligible for ART (CD4≤350 cells/μL). FINDINGS: 3,393 adults were tested for HIV (96% coverage), of whom 635 (19%) were HIV positive. At baseline, 36% of HIV positive persons were newly identified (64% were previously known to be HIV positive) and 40% were taking ART. By month 12, 619 (97%) of HIV positive persons visited an HIV clinic, and of 123 ART eligible participants, 94 (76%) initiated ART by 12 months. Of the 77 participants on ART by month 9, 59 (77%) achieved viral suppression by month 12. Among all HIV positive persons, the proportion with viral suppression (<1,000 copies/mL) increased from 50% to 65% (p=<0.001) at 12 months. INTERPRETATION: Community-based HTC in rural South Africa and Uganda achieved high testing coverage and linkage to care. Among those eligible for ART, a high proportion initiated ART and achieved viral suppression, indicating high adherence. Implementation of this HTC approach by existing community health workers in Africa should be evaluated to determine effectiveness and costs.
Entities:
Keywords:
Community-based HIV testing and counseling (HTC); HIV infectiousness; HIV prevention and care; community viral load; home HTC; linkage to care; point-of-care CD4
Authors: Edward J Mills; Celestin Bakanda; Josephine Birungi; Keith Chan; Nathan Ford; Curtis L Cooper; Jean B Nachega; Mark Dybul; Robert S Hogg Journal: Ann Intern Med Date: 2011-07-18 Impact factor: 25.391
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Ramzi A Alsallaq; Jared M Baeten; Connie L Celum; James P Hughes; Laith J Abu-Raddad; Ruanne V Barnabas; Timothy B Hallett Journal: PLoS One Date: 2013-01-23 Impact factor: 3.240
Authors: Sheri A Lippman; Starley B Shade; Alison M El Ayadi; Jennifer M Gilvydis; Jessica S Grignon; Teri Liegler; Jessica Morris; Evasen Naidoo; Lisa M Prach; Adrian Puren; Scott Barnhart Journal: J Acquir Immune Defic Syndr Date: 2016-09-01 Impact factor: 3.731
Authors: Clement Zeh; Charles E Rose; Seth Inzaule; Mitesh A Desai; Fredrick Otieno; Felix Humwa; Benta Akoth; Paul Omolo; Robert T Chen; Yenew Kebede; Taraz Samandari Journal: J Immunol Methods Date: 2017-05-18 Impact factor: 2.303
Authors: Laura M Bogart; Glenn J Wagner; William Musoke; Rose Naigino; Sebastian Linnemayr; Emily Maistrellis; David J Klein; Riana B Jumamil; Barbara Mukasa; Ingrid V Bassett; Thomas P Giordano; Rhoda K Wanyenze Journal: AIDS Behav Date: 2017-02
Authors: Niklaus D Labhardt; Isaac Ringera; Thabo I Lejone; Thomas Klimkait; Josephine Muhairwe; Alain Amstutz; Tracy R Glass Journal: JAMA Date: 2018-03-20 Impact factor: 56.272
Authors: Ruanne V Barnabas; Heidi van Rooyen; Elioda Tumwesigye; Justin Brantley; Jared M Baeten; Alastair van Heerden; Bosco Turyamureeba; Philip Joseph; Meighan Krows; Katherine K Thomas; Torin T Schaafsma; James P Hughes; Connie Celum Journal: Lancet HIV Date: 2016-03-10 Impact factor: 12.767
Authors: Meredith E Clement; Lauren F Collins; Julius M Wilder; Michael Mugavero; Taryn Barker; Susanna Naggie Journal: Infect Dis Clin North Am Date: 2018-06 Impact factor: 5.982